On Monday, Nevada Attorney General Adam Laxalt announced the allocation of $1.2 million to the University of Nevada, Reno’s School of Medicine for a new OB/GYN department. 

The new department will provide education for medical students, as well as training for primary care residents and residents.

The funding is part of $3.8 million that the School of Medicine will receive over five years, resulting from a settlement between Pfizer pharmaceutical company and the State of Nevada. The AG’s Office says the settlement resolved claims that Pfizer had unlawfully promoted certain postmenopausal hormone therapy medications. 

“My office is proud to partner with the University of Nevada, Reno School of Medicine to make a lasting investment in women’s health,” said Attorney General Laxalt. “We are confident that women’s health care in Nevada will benefit greatly from these settlement funds.” 

(Nevada Attorney General Adam Laxalt’s Office contributed to this report.)